These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 9741516

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

  • 24. Early statin therapy restores endothelial function in children with familial hypercholesterolemia.
    de Jongh S, Lilien MR, op't Roodt J, Stroes ES, Bakker HD, Kastelein JJ.
    J Am Coll Cardiol; 2002 Dec 18; 40(12):2117-21. PubMed ID: 12505222
    [Abstract] [Full Text] [Related]

  • 25. Effect of acute changes in oxygen tension on flow-mediated dilation. Relation to cardivascular risk.
    Frøbert O, Holmager P, Jensen KM, Schmidt EB, Simonsen U.
    Scand Cardiovasc J; 2008 Feb 18; 42(1):38-47. PubMed ID: 17852792
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Endothelial vasodilator function is related to low-density lipoprotein particle size and low-density lipoprotein vitamin E content in type 1 diabetes.
    Skyrme-Jones RA, O'Brien RC, Luo M, Meredith IT.
    J Am Coll Cardiol; 2000 Feb 18; 35(2):292-9. PubMed ID: 10676672
    [Abstract] [Full Text] [Related]

  • 29. Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia.
    Gilligan DM, Sack MN, Guetta V, Casino PR, Quyyumi AA, Rader DJ, Panza JA, Cannon RO.
    J Am Coll Cardiol; 1994 Dec 18; 24(7):1611-7. PubMed ID: 7963105
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study.
    Ostad MA, Eggeling S, Tschentscher P, Schwedhelm E, Böger R, Wenzel P, Meinertz T, Munzel T, Warnholtz A.
    Atherosclerosis; 2009 Jul 18; 205(1):227-32. PubMed ID: 19150064
    [Abstract] [Full Text] [Related]

  • 32. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
    Bays HE, Ose L, Fraser N, Tribble DL, Quinto K, Reyes R, Johnson-Levonas AO, Sapre A, Donahue SR, Ezetimibe Study Group.
    Clin Ther; 2004 Nov 18; 26(11):1758-73. PubMed ID: 15639688
    [Abstract] [Full Text] [Related]

  • 33. Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial.
    Goldberg AC, Sapre A, Liu J, Capece R, Mitchel YB, Ezetimibe Study Group.
    Mayo Clin Proc; 2004 May 18; 79(5):620-9. PubMed ID: 15132403
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effect of atorvastatin on peripheral endothelial function and systemic inflammatory markers in patients with stable coronary artery disease.
    Alber HF, Frick M, Süssenbacher A, Dörler J, Dichtl W, Stocker EM, Pachinger O, Weidinger F.
    Wien Med Wochenschr; 2007 Feb 18; 157(3-4):73-8. PubMed ID: 17340064
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Effect of treatment with pravastatin or ezetimibe on endothelial function in patients with moderate hypercholesterolemia.
    Grigore L, Raselli S, Garlaschelli K, Redaelli L, Norata GD, Pirillo A, Catapano AL.
    Eur J Clin Pharmacol; 2013 Mar 18; 69(3):341-6. PubMed ID: 22777149
    [Abstract] [Full Text] [Related]

  • 40. [Improved coronary vasodilator capacity by drug lipid lowering therapy in patients in the early stage of coronary atherosclerosis with reduced coronary reserves and moderate LDL hypercholesteremia].
    Baller D, Gleichmann U, Notohamiprodjo G, Weise R, Holzinger J, Montanus H, Betker S, Lehmann J.
    Z Kardiol; 1998 Mar 18; 87 Suppl 2():136-44. PubMed ID: 9827472
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.